Variational Autoencoder Process Monitoring Patents 2026
Variational Autoencoder for Process Monitoring
VAEs have become a foundational architecture for unsupervised fault detection and anomaly monitoring across manufacturing, biopharma, semiconductors, and telecoms. This landscape maps filings and publications from 2018 through mid-2026.
VAE Process Monitoring: From Research Prototype to Production IP
Variational Autoencoders function as probabilistic encoder-decoder architectures that compress high-dimensional process data into a structured latent space governed by a learned Gaussian distribution, then reconstruct outputs. Deviations in reconstruction error or latent-space KL divergence statistics serve as monitoring signals for fault detection and anomaly diagnosis.
The dataset spans foundational architecture research from 2019 to 2021, applied industrial patents from 2020 to 2026, and domain-specific extensions including recurrent VAEs for time-series data, conditional VAEs for batch processes, and just-in-time learning VAEs for real-time adaptive calibration. The core technical problem addressed across most records is detection of faults where labeled fault data is scarce or absent.
The most recent filings in the dataset, dated 2025 to 2026, indicate active technology maturation. Tata Consultancy Services received active US status in March 2026 for sensor drift identification, Jiangnan University’s CDVAE batch monitoring patent achieved active CN status in April 2026, and L3Harris Technologies’ VAE anomaly recognition patent achieved active US status in May 2026.
In this dataset, 8 distinct named assignees hold filings across 7 jurisdictions, including CN, US, WO, DE, EP, IN, and AU. Telefonaktiebolaget LM Ericsson and IBM each lead with 5 filings in retrieved records, followed by Amgen and Tata Consultancy Services with 4 filings each in this dataset.
Technology Cluster Distribution and Filing Timeline
Four core technology clusters emerge from the retrieved records: static and recurrent VAE fault detection, conditional and batch-process VAE architectures, continual and just-in-time VAE learning, and distributed or network-scale VAE anomaly monitoring. Filing activity in this dataset spans 2019 through 2026, with a clear mid-period industrialization cluster from 2021 to 2023.
Patent Records by Technology Cluster — VAE Process Monitoring (Dataset Snapshot)
In this dataset, the static and recurrent VAE fault detection cluster accounts for the largest share of records, followed by conditional batch-process VAE and distributed network-scale VAE architectures.
↗ Click bars to exploreVAE Process Monitoring Filings by Period — Dataset Timeline
In this dataset, filing activity shows clear periodization: foundational research clusters in 2019–2020, industrialization filings in 2021–2023, and active patent grants and new filings concentrated in 2024–2026.
↗ Click bars to exploreVAE Process Monitoring Across Key Industry Verticals
The retrieved records cover six distinct application verticals where VAE-based monitoring architectures have been deployed or patented: industrial manufacturing, biopharmaceutical manufacturing, telecommunications, semiconductor EDA, automotive battery systems, and IT operations and cloud monitoring.
Batch Fermentation & Chemical Manufacturing
Jiangnan University filed three CN patents (2023–2026) applying CDVAE and LSTM-CVAE architectures to multi-phase batch processes including lactic acid bacteria fermentation. Control limits are computed using kernel density estimation on KL-divergence and residual-space statistics. The CDVAE batch monitoring patent achieved active CN status in April 2026.
Batch Process MonitoringBiopharmaceutical Cell Culture Bioreactors
Amgen Inc. filed a JIT-VAE patent family (US, WO, AU, CN — 2024–2025) for bioreactor cell culture process monitoring. The architecture queries spectral scan data against a VAE-encoded historical database to produce adaptive local calibration models for real-time analytical prediction. This represents the most prominent single-assignee biopharma cluster in this dataset.
Biopharmaceutical ManufacturingTelecom Network & Radio Resource Management
Ericsson holds 5 filings in this dataset across WO, US, CN, and CA jurisdictions covering VAE-based traffic distribution prediction for radio resource configuration (WO 2021, US 2023/2025) and a feature-selective digital twin emulator for device verification and anomaly checking (WO 2023). The VAE learns historical traffic flow distributions to predict future states and enable proactive parameter configuration.
TelecommunicationsIT Operations & Cloud Platform Monitoring
IBM filed a conditional VAE system for synthetic observability data generation (US, February and June 2025, active) and Agricultural Bank of China filed a VAE-based cloud platform early warning method (CN, March 2025). China Unicom filed a VAE-based log analysis patent for container log anomaly detection (CN, 2024). CVAEs generate synthetic logs and traces preserving statistical associations for monitoring purposes.
IT Operations MonitoringKey Patent Assignees in VAE Process Monitoring (Retrieved Records)
In this dataset, Telefonaktiebolaget LM Ericsson and IBM each account for 5 retrieved filings across multiple jurisdictions, followed by Amgen and Tata Consultancy Services with 4 filings each in retrieved records. Academic assignees including Jiangnan University and Northwestern Polytechnical University hold active CN patents but show limited PCT or US coverage in this dataset.
Top Assignees by Filing Count — VAE Process Monitoring (Dataset Snapshot)
↗ Click bars to exploreAmgen Inc.
Amgen holds 4 filings in this dataset (US, WO, AU, CN — 2024–2025), all within the just-in-time VAE learning architecture for cell culture bioreactor process monitoring and control. The JIT-VAE queries spectral scan data against a VAE-encoded historical database to produce adaptive local calibration models. Filings are active across multiple jurisdictions, reflecting a broad global IP protection strategy for biopharma process monitoring.
United StatesTata Consultancy Services Limited
Tata Consultancy Services holds 4 filings in this dataset across US, EP, and IN jurisdictions, focused on continual-training VAE frameworks for identifying sensor drifts and varying operational conditions. The core patent family was filed with an Indian priority in March 2022 and published across US and EP in September 2023. The US filing received active status in March 2026, confirming production-grade IP protection for adaptive industrial monitoring.
India — INNext-Generation VAE Process Monitoring Trends (2024–2026)
Filings dated 2024 to 2026 in this dataset indicate five prominent emerging directions: adaptive and continual VAE learning, IT operations and cloud platform monitoring, energy-based VAE hybrids, distributed and federated VAE frameworks, and battery and predictive maintenance integration.
Adaptive Continual VAE Learning for Non-Stationary Processes
Tata Consultancy Services’ continual-training VAE framework received active US patent status in March 2026, and Amgen’s JIT-VAE was extended to AU jurisdiction in 2025. These approaches use VAE-based generative rehearsal or latent-space similarity queries to adapt continuously to evolving operating conditions without full retraining. This direction is considered critical for industrial deployments where process characteristics change over product campaigns or equipment lifetimes.
IT Operations and Cloud Platform VAE Monitoring
IBM filed a conditional VAE system for synthetic observability data generation in the US in February and June 2025, and Agricultural Bank of China filed a VAE-based cloud platform early warning method in CN in March 2025. The use of CVAEs to generate synthetic logs and traces that preserve statistical associations is identified in the dataset as a particularly novel direction for IT/cloud operational intelligence. China Unicom’s VAE log analysis patent (CN, 2024) further confirms this sub-domain’s emergence.
Static VAE vs. Conditional/Recurrent VAE for Process Monitoring
Click any row to explore further.
| Dimension | Static VAE | Conditional / Recurrent VAE (CVAE, LSTM-VAE) |
|---|---|---|
| Primary monitoring signal | Reconstruction error (residual space) | KL divergence (latent space) + reconstruction error combined statistic |
| Temporal dynamics | Not captured; treats each observation independently | Captured via LSTM or GRU layers encoding sequential process behavior |
| Multi-phase batch processes | High false-alarm rates due to multi-modal process distributions | Phase labels or batch metadata injected as conditioning signals; reduces false alarms |
| Fault diagnosis capability | Reconstruction-based contribution diagrams | Deep contribution plots in latent and residual domains |
| Adaptability to concept drift | Requires periodic full retraining | Continual-training VAE (Tata Consultancy Services, active US 2026) uses generative rehearsal |
| Representative assignees | Northwestern Polytechnical University (CN, 2023), Hangzhou Jingye (CN, 2024) | Jiangnan University (CN, 2023–2026), Amgen (US/WO/AU/CN, 2024–2025), Tata Consultancy Services (US/EP/IN) |
| IP coverage outside China | Limited; primarily CN jurisdiction in this dataset | Broader; US, WO, EP, AU, IN jurisdictions present in this dataset |
| Application domain fit | Continuous steady-state processes; sheet metal forming; single-mode sensor data | Batch fermentation, bioreactor cell culture, multi-unit distributed industrial networks |
Frequently Asked Questions: VAE Process Monitoring Patents
According to the retrieved dataset, the core technical problem addressed across most records is detection of faults or anomalies in processes where labeled fault data is scarce or absent, making unsupervised or semi-supervised VAE-based approaches highly practical.
In this dataset, Telefonaktiebolaget LM Ericsson and International Business Machines Corporation each have 5 filings, followed by Amgen Inc. and Tata Consultancy Services Limited with 4 filings each, Jiangnan University and Robert Bosch GmbH with 3 filings each, and L3Harris Technologies with 2 filings.
Just-in-time (JIT) VAE approaches query historical observation databases using VAE-encoded latent distributions to dynamically select the most relevant training data for a local calibration model. Amgen Inc. holds the key patent family (US, WO, AU, CN — 2024–2025) targeting bioreactor cell culture process monitoring.
A CDVAE (conditional deep VAE) incorporates phase labels, batch metadata, or stage annotations as conditioning inputs, addressing multi-phase, multi-modal manufacturing processes where standard VAEs produce high false-alarm rates. Control limits in CDVAE systems are computed using kernel density estimation on KL-divergence and residual-space statistics, as described in Jiangnan University’s CN patents (2023–2026).
China (CN) is described as the most active jurisdiction for process-specific VAE monitoring patents in this dataset, with filings from Jiangnan University, Northwestern Polytechnical University, Hangzhou Jingye, Agricultural Bank of China, RealAI, and China Unicom. The United States shows the broadest commercial assignee diversity, with IBM, Amgen, L3Harris, Tata Consultancy Services, Amazon, and Nvidia all filing in the US jurisdiction.
According to the strategic implications section of the dataset, JIT and continual learning represent the highest-value process monitoring IP direction. Amgen’s global filing strategy around JIT-VAE and Tata Consultancy Services’ continual-training VAE with active US status in March 2026 suggest that adaptive, non-stationary-aware monitoring is where premium commercial value is being asserted.
Data and insights on this page are based on a limited patent and literature dataset and are for reference only. Figures may not represent the complete technology landscape.